BioCentury
ARTICLE | Company News

Shionogi sales and marketing update

May 13, 2013 7:00 AM UTC

Shionogi launched Osphena ospemifene in the U.S. to treat moderate to severe dyspareunia due to postmenopausal vulvovaginal atrophy. The wholesale acquisition cost is $158 for 30 once-daily tablets. ...